Skip to content
The Policy VaultThe Policy Vault

Creon — CareFirst (Caremark)

Exocrine pancreatic insufficiency due to cystic fibrosis

Initial criteria

  • The requested drug is being prescribed for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions
  • If the request is for Viokace, the patient will take Viokace in combination with a proton pump inhibitor (PPI)

Approval duration

12 months